Literature DB >> 2916512

Home oxygen therapy for chronic lung disease in extremely low-birth-weight infants.

B B Hudak1, M C Allen, M L Hudak, G M Loughlin.   

Abstract

Chronic lung disease that requires prolonged oxygen therapy commonly complicates the recovery of extremely low-birth-weight infants (less than 1000 g). We report follow-up data through 18.5 +/- 0.9 (mean +/- SEM) months of age in 30 extremely low-birth-weight infants (birth weight, 783 +/- 24 g; gestational age, 26.0 +/- 0.3 weeks) who were discharged home receiving supplemental oxygen. Oxygen was prescribed to maintain arterial oxygen saturation at 95% or greater. At discharge, postconceptional age was 40.5 +/- 0.6 weeks, and weight was 2220 +/- 50 g. Duration of home oxygen therapy was 4.5 +/- 0.5 months. The mean weight percentile increased from less than 5 to 23 between discharge and the last follow-up. All infants survived; only 6 required hospitalization for acute medical illnesses. We conclude that carefully supervised home oxygen therapy permits the safe early discharge of selected extremely low-birth-weight infants with chronic lung disease.

Entities:  

Mesh:

Year:  1989        PMID: 2916512     DOI: 10.1001/archpedi.1989.02150150115028

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  8 in total

1.  Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation.

Authors:  W Tin; D W Milligan; P Pennefather; E Hey
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-03       Impact factor: 5.747

Review 2.  A risk-benefit assessment of drugs used for neonatal chronic lung disease.

Authors:  D G Sweet; H L Halliday
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

Review 3.  Home oxygen for children: who, how and when?

Authors:  I M Balfour-Lynn; R A Primhak; B N J Shaw
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

4.  Clinical predictors and institutional variation in home oxygen use in preterm infants.

Authors:  Joanne Lagatta; Reese Clark; Alan Spitzer
Journal:  J Pediatr       Date:  2011-09-29       Impact factor: 4.406

5.  Growth Outcomes of Preterm Infants Exposed to Different Oxygen Saturation Target Ranges from Birth.

Authors:  Cristina T Navarrete; Lisa A Wrage; Waldemar A Carlo; Michele C Walsh; Wade Rich; Marie G Gantz; Abhik Das; Kurt Schibler; Nancy S Newman; Anthony J Piazza; Brenda B Poindexter; Seetha Shankaran; Pablo J Sánchez; Brenda H Morris; Ivan D Frantz; Krisa P Van Meurs; C Michael Cotten; Richard A Ehrenkranz; Edward F Bell; Kristi L Watterberg; Rosemary D Higgins; Shahnaz Duara
Journal:  J Pediatr       Date:  2016-06-22       Impact factor: 4.406

6.  Neurodevelopmental outcome of preterm infants with bronchopulmonary dysplasia.

Authors:  P H Gray; Y R Burns; H A Mohay; M J O'Callaghan; D I Tudehope
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-11       Impact factor: 5.747

7.  Elevated carbon dioxide tension as a predictor of subsequent adverse events in infants with bronchopulmonary dysplasia.

Authors:  Thomas Kovesi; Adel Abdurahman; Marc Blayney
Journal:  Lung       Date:  2006 Jan-Feb       Impact factor: 3.777

8.  Impact of a protocol-driven unified service for neonates with bronchopulmonary dysplasia.

Authors:  Natalie Batey; Dushyant Batra; Jon Dorling; Jayesh Mahendra Bhatt
Journal:  ERJ Open Res       Date:  2019-03-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.